Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases is a research paper published in The Journal of Experimental Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Union's Horizon 2020 research and innovation program
Grant: 824110
European Advanced infraStructure for Innovative Genomics
French Foundation for Medical Research
Grant: EQU201903007798
French National Research Agency
Grant: ANR-10-IAHU-01
Next Generation EU-MUR PNRR
Grant: PE00000007
NIGMS NIH HHS
Grant: T32 GM136547
University Grenoble Alpes
Grant: ANR-17-EURE-0003
NIA NIH HHS
Grant: K01 AG072789
Swedish Research Council
Grant: 2021-03118
Japan Agency for Medical Research and Development
Grant: JP22fk0108514
Qatar National Research Fund
Grant: NPRP9-251-3-045
NCATS NIH HHS
Grant: UL1 TR001866
Göran Gustafsson Foundation
Grant: 2141
Japan Society for the Promotion of Science
Grant: 22H03041
NIAID NIH HHS
Grant: R01 AI163029
HORIZON-HLTH-2021-DISEASE-04
Grant: 101057100
The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine
French National Research Agency (ANR)
Grant: ANR-23-CE15-0011
Autoinflammation in patients with inherited IRAK4 deficiency: a paradox
National Institutes of Health
Grant: 5R01AI163029-04
Inborn errors of immunity in patients with life-threatening COVID-19
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
French National Research Agency (ANR)
Grant: ANR-22-CE15-0046
Autoantibodies against Interferons underlying Infectious Diseases
French National Research Agency (ANR)
Grant: ANR-21-CE17-0014
KREMEN2, an inhibitor of NF-kB-mediated auto-inflammation involved in human genetic disease
Square Foundation
Association Incontinentia Pigmenti France
Paris Cité University
Chan-Zuckerberg Biohub
Filière Santé Maladies Rares Dermatologiques
SCOR Corporate Foundation for Science
Bettencourt-Schueller Foundation
St. Giles Foundation
General Atlantic Foundation
Howard Hughes Medical Institute
Grandir - Fonds de solidarité pour l'enfance
Rockefeller University
Imagine Institute
Institut National de la Santé et de la Recherche Médicale
French Ministry of Higher Education, Research, and Innovation
National Center for Advancing Sciences
National Institute of Allergy and Infectious Diseases
Sidra Medicine
Rockefeller University
National Institute of Allergy and Infectious Diseases
Sidra Medicine
Chan-Zuckerberg Biohub
Imagine Institute
Filière Santé Maladies Rares Dermatologiques
National Center for Advancing Sciences
Grandir - Fonds de solidarité pour l'enfance
Institut National de la Santé et de la Recherche Médicale
French Ministry of Higher Education, Research, and Innovation
Howard Hughes Medical Institute
Square Foundation
Association Incontinentia Pigmenti France
SCOR Corporate Foundation for Science
St. Giles Foundation
Bettencourt-Schueller Foundation
General Atlantic Foundation
Paris Cité University
FWCI
6.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals